Here in this cohort with high frequency of comorbidities and use of concomitant medications, we found that continuation rates over 6 months of treatment with tadalafil OaD were comparable across ...

INDIANAPOLIS, Oct. 12, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that a pivotal Phase III study of Cialis® (tadalafil) tablets 5 mg for once daily use met its co-primary ...

INDIANAPOLIS, July 16, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that study results published in the Journal of Sexual Medicine showed a greater percentage of men who had ...

INDIANAPOLIS, Jan 08, 2008 -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Cialis® (tadalafil)(1) for once daily use (2.5 mg and 5 ...

Men with ED of all severities who were in stable heterosexual relationships were eligible for the base studies if they agreed to make ⩾4 intercourse attempts during a 4-week treatment-free run-in and ...

However, EF improvement is not the only factor that is crucial to resuming a satisfying sex life. In addition to general concerns regarding efficacy or tolerability and patient or partner preference ...

Study Data Shows Cialis 5 mg Initiated with Finasteride Provides Significantly Greater Improvements in Urinary Symptoms of Benign Prostatic Hyperplasia than Placebo with Finasteride INDIANAPOLIS, Oct.

Take Cialis at least two hours before sex for the best results. Avoid heavy meals and limit alcohol before taking Cialis. Always follow your healthcare provider's prescribed dosage and don't change it ...

Daily treatment with tadalafil may result in significantly improved erectile function in men who have an incomplete response to the maximum dose of a phosphodiesterase type 5 (PDE5) inhibitor taken as ...

You might have seen Cialis — the (ED) drug — available in doses ranging from 2.5 mg to 20 mg. Surely, more is better right? Well, not always. Cialis 20 mg is an effective ED treatment, but so are the ...

EDATE was a prospective, longitudinal, observational study conducted in 59 centres across Germany, France, Italy, and Greece, enrolling patients from November 2011 through June 2012. [20] Adult male ...